Literature DB >> 19275534

A multi-step NMR screen for the identification and evaluation of chemical leads for drug discovery.

Kelly A Mercier1, Matthew D Shortridge, Robert Powers.   

Abstract

A multi-step NMR based screening assay is described for identifying and evaluating chemical leads for their ability to bind a target protein. The multi-step NMR assay provides structure-related information while being an integral part of a structure based drug discovery and design program. The fundamental principle of the multi-step NMR assay is to combine distinct 1D and 2D NMR techniques, in such a manner, that the inherent strengths and weakness associated with each technique is complementary to each other in the screen. By taking advantage of the combined strengths of 1D and 2D NMR experiments, it is possible to minimize protein requirements and experiment time and differentiate between non-specific and stoichiometric binders while being able to verify ligand binding, determine a semi-quantitative dissociation constant, identify the ligand binding site and rapidly determine a protein-ligand co-structure. Furthermore, the quality and physical behavior of the ligand is readily evaluated to determine its appropriateness as a chemical lead. The utility of the multi-step NMR assay is demonstrated with the use of PrgI from Salmonella typhimurium and human serum albumin (HSA) as target proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275534      PMCID: PMC6620029          DOI: 10.2174/138620709787581738

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  10 in total

1.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

Review 2.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

3.  NMR Metabolomics Protocols for Drug Discovery.

Authors:  Fatema Bhinderwala; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

4.  Correlation between protein function and ligand binding profiles.

Authors:  Matthew D Shortridge; Michael Bokemper; Jennifer C Copeland; Jaime L Stark; Robert Powers
Journal:  J Proteome Res       Date:  2011-03-22       Impact factor: 4.466

5.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

6.  Research in bioanalysis and separations at the University of Nebraska - Lincoln.

Authors:  David S Hage; Eric D Dodds; Liangcheng Du; Robert Powers
Journal:  Bioanalysis       Date:  2011-05       Impact factor: 2.681

7.  Statistical removal of background signals from high-throughput (1)H NMR line-broadening ligand-affinity screens.

Authors:  Bradley Worley; Nicholas J Sisco; Robert Powers
Journal:  J Biomol NMR       Date:  2015-07-09       Impact factor: 2.835

8.  Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?

Authors:  Luca G Mureddu; Geerten W Vuister
Journal:  Front Mol Biosci       Date:  2022-02-18

9.  Structural and functional similarity between the bacterial type III secretion system needle protein PrgI and the eukaryotic apoptosis Bcl-2 proteins.

Authors:  Matthew D Shortridge; Robert Powers
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

10.  A simple and sensitive detection of the binding ligands by using the receptor aggregation and NMR spectroscopy: a test case of the maltose binding protein.

Authors:  Young Kee Chae; Yoonjin Um; Hakbeom Kim
Journal:  J Biomol NMR       Date:  2021-09-15       Impact factor: 2.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.